CompletedNot Applicable

Anxiety Lowering and Deprescribing Through Emotion Regulation

United States33 participantsStarted 2024-05-16

Plain-language summary

The goal of this clinical trial is to test ALDER (Anxiety Lowering and Deprescribing through Emotion Regulation), an online self-guided positive emotion intervention, in patients over the age of 65 who are candidates for benzodiazepine receptor agonist (BZRA, commonly called benzos, or z-drugs) deprescribing. The main questions it aims to answer are: * Is ALDER relevant to and satisfactory for older adult BZRA users? * Does ALDER help to increase positive emotions and decrease anxiety, trouble sleeping, and use of BZRA medications? Participants will complete the 5-week online self-guided ALDER intervention as well as two survey assessments, one before the intervention and one after.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 65 and over. * ≥1 NM Internal Medicine clinic visit within the past year. * BZRA prescribed by NM primary care within the past year. * Takes BZRA at least twice a week. * Daily access to internet-connected device. * Ability to read and speak English. Exclusion Criteria: * Dementia, seizure, or REM sleep disorder diagnosis. * In hospice care. * No daily internet access. * Cannot speak and read English.

What they're measuring

Feasibility of Intervention

Timeframe: Measured post-intervention (7-weeks).

Acceptability of Intervention

Timeframe: Measured post-intervention (7-weeks).

Adoption of Intervention

Timeframe: Measured post-intervention (7-weeks).

Trial details

NCT IDNCT06359314

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-05

Results submitted2025-09-15

View on ClinicalTrials.gov More Benzodiazepine Dependence trials